Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2020

Sep 16, 2020

32566_dirs_2020-09-16_e906ccfe-e727-4738-b8df-5f0dddc25a90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-09-15

Reporting Person: Ford Alexander (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-15 Common Stock S 2804 $13.7769 Disposed 151159 Direct